Diflucan and Gaviscon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diflucan (fluconazole) and Gaviscon (aluminum hydroxide; magnesium trisilicate). Common drug interactions include anxiety among females and rhabdomyolysis among males.

The phase IV clinical study analyzes what interactions people have when they take Diflucan and Gaviscon. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Diflucan?

Diflucan has active ingredients of fluconazole. It is often used in vaginal yeast infection. eHealthMe is studying from 28,471 Diflucan users. Check the latest studies of Diflucan.

What is Gaviscon?

Gaviscon has active ingredients of aluminum hydroxide; magnesium trisilicate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 12,355 Gaviscon users. Check the latest studies of Gaviscon.



On Jul, 04, 2026

41 people who take Diflucan and Gaviscon together, and have interactions are studied.

Diflucan and Gaviscon drug interactions.

What are the common drug interactions of Diflucan and Gaviscon, by gender? *:

female:

  1. Anxiety
  2. Urinary tract infection
  3. Depression
  4. Fall
  5. Headache (pain in head)
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Dehydration (dryness resulting from the removal of water)
  8. Diarrhoea
  9. Fatigue (feeling of tiredness)
  10. Infusion site extravasation (flow of (blood or lymph) from infusion site)

male:

  1. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  2. Cardiac arrest
  3. Diarrhoea
  4. Dyspnoea (difficult or laboured respiration)
  5. Fall
  6. Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
  7. Tachypnoea (a condition of rapid breathing over 20 per minute)

What are the common drug interactions of Diflucan and Gaviscon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Chronic kidney disease
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Cholecystitis acute (rapid infection of gallbladder)
  5. Gallbladder disorder
  6. General physical health deterioration (weak health status)
  7. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  8. Injury
  9. Nephrogenic anaemia (anaemia due to kidney disease)
  10. Nephropathy (damage to or disease of a kidney)

30-39:

n/a

40-49:

  1. Chronic kidney disease
  2. Anxiety
  3. Depression
  4. Renal failure (kidney dysfunction)
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Suicidal ideation
  7. Bacterial infection
  8. Gamma-glutamyltransferase increased
  9. Abdominal pain
  10. Antiphospholipid syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss)

50-59:

  1. Dysgeusia (disorder of the sense of taste)
  2. Eructation (release of gas from the digestive tract)
  3. Loose stools
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Nausea (feeling of having an urge to vomit)
  6. Sluggishness (lacking alertness)
  7. Weakness
  8. Weight decreased
  9. Chronic kidney disease
  10. Diarrhoea

60+:

  1. Urinary tract infection
  2. Pain
  3. Vulvovaginal candidiasis (vulvovaginal infection by fungi)
  4. Abdominal pain
  5. Abdominal pain lower
  6. Abdominal pain upper
  7. Activities of daily living impaired
  8. Alopecia (absence of hair from areas of the body)
  9. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  10. Anxiety

What are the existing conditions these people have? *

  1. Infection: 14 people, 34.15%
  2. High Blood Cholesterol: 13 people, 31.71%
  3. Insomnia (sleeplessness): 13 people, 31.71%
  4. Pain: 12 people, 29.27%
  5. Hypersensitivity: 12 people, 29.27%
  6. Stress And Anxiety: 10 people, 24.39%
  7. Depression: 9 people, 21.95%
  8. Diabetes: 9 people, 21.95%
  9. Hypokalemia (low potassium): 8 people, 19.51%
  10. Headache (pain in head): 8 people, 19.51%

* Approximation only. Some reports may have incomplete information.

Do you take Diflucan and Gaviscon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Diflucan and Gaviscon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Diflucan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gaviscon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diflucan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gaviscon and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluconazole and aluminum hydroxide; magnesium trisilicate (the active ingredients of Diflucan and Gaviscon, respectively), and Diflucan and Gaviscon (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: